Purpose of Review <p>Photoacoustic tomography (PAT) has emerged as a promising non-ionizing imaging modality that leverages optical absorption contrast to provide anatomical, functional, and metabolic insights. This review highlights recent advancements in PAT for assessing hemodynamics and metabolic function in the diagnosis, treatment, and monitoring of cardiovascular diseases (CVDs).</p> Recent Findings <p>PAT has been applied to evaluate vascular morphology, blood flow, perfusion, and cardiac hemodynamics. It has also been used for metabolic assessments, including oxygenation, lipid accumulation, glucose dynamics, collagen distribution, and inflammatory responses.</p> Summary <p>By selecting appropriate wavelengths, PAT can target specific molecular contrasts, while multi-wavelength imaging enables simultaneous visualization of multiple biomarkers. These capabilities provide a comprehensive view of CVD progression and treatment. Ongoing technological advancements, clinical trials, and translational efforts are essential for validating PAT’s clinical utility and accelerating its integration into routine cardiovascular care.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Photoacoustic Tomography in Cardiovascular Medicine: Innovations in Assessing Hemodynamics and Metabolic Function

  • Yilin Luo,
  • Lihong V. Wang

摘要

Purpose of Review

Photoacoustic tomography (PAT) has emerged as a promising non-ionizing imaging modality that leverages optical absorption contrast to provide anatomical, functional, and metabolic insights. This review highlights recent advancements in PAT for assessing hemodynamics and metabolic function in the diagnosis, treatment, and monitoring of cardiovascular diseases (CVDs).

Recent Findings

PAT has been applied to evaluate vascular morphology, blood flow, perfusion, and cardiac hemodynamics. It has also been used for metabolic assessments, including oxygenation, lipid accumulation, glucose dynamics, collagen distribution, and inflammatory responses.

Summary

By selecting appropriate wavelengths, PAT can target specific molecular contrasts, while multi-wavelength imaging enables simultaneous visualization of multiple biomarkers. These capabilities provide a comprehensive view of CVD progression and treatment. Ongoing technological advancements, clinical trials, and translational efforts are essential for validating PAT’s clinical utility and accelerating its integration into routine cardiovascular care.